Exploring The Clinical Significance Of Anacardiaceae Family In Homoeopathic Management Of Arthritis

Abstract

This article explores the clinical significance of the Anacardiaceae family in homoeopathy, with a focus on its efficacy in addressing arthritis. The study delves into historical roots, Materia Medica, and clinical case studies to provide a comprehensive overview. A single-center interventional study was conducted at Venkateswara Homoeopathic Medical College and Hospital, analyzing data from June to December 2022. The sample of 75 clinically diagnosed arthritis cases underwent treatment with homoeopathic Anacardiaceae family medicines, and outcomes were assessed using the Routine Assessment of Patient Index Data 3 (RAPID3) tool. Statistical analyses revealed a significant mean difference (1.865) with a p-value of 0.000, indicating tangible improvements in physical function, pain, and overall well-being. Rhus toxicodendron demonstrated a substantial 52.0% improvement, emphasizing its historical significance in joint-related issues. Anacardium orientale, Magnifera indica, and Anacardium occidentalis also showed efficacy. Demographic analysis suggested potential gender-related variations in arthritis prevalence and treatment responses. The correlation between miasm and disease was established, supporting personalized homoeopathic interventions. Despite limitations, including the single-center design and a 7-month duration, the study contributes to the growing evidence supporting the role of homoeopathic medicines of Anacardiaceae family in the management of arthritis. The observed improvements across diverse forms of arthritis underscore their broad applicability, advocating for further multi-center studies with extended follow-up periods. As holistic healthcare evolves, the Anacardiaceae family emerges as a promising avenue for enhancing the quality of life in individuals with arthritis, urging continued exploration and application in mainstream rheumatic disease management.